ROOK, ALAIN H.,GELFAND, JOEL M.,WYSOCKA, MARIA M.,BENOIT, BERNICE M.
申请号：
EP14735313
公开号：
EP2941233A4
申请日:
2014.01.06
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present invention provides methods for treating a subject with cutaneous T cell lymphoma (CTCL). In certain embodiments, a subject is administered an effective amount effective of an IRM compound wherein at least one symptom or clinical sign of CTCL is ameliorated. The present invention further includes a method of increasing a cell-mediated immune response of a cell population that includes cells affected by CTCL. In certain embodiments, an effective amount of the cell population is contacted with an IRM compound wherein at least one cell-mediated immune activity of the cell population is increased.
